TheraRadar
← Back
Data updated: Mar 29, 2026

TIANJIN KINGYORK

Pharmaceuticals
Generics

TIANJIN KINGYORK is a generic drug manufacturer with 1 FDA-approved products.

2021
Since
1
Drugs
-
Trials
12
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

METHYLPREDNISOLONE SODIUM SUCCINATE 2025-07-03
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2025-07-03
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2025-07-03
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2025-07-03
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2025-02-19
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2024-12-19
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2024-11-13
Labeling
METHYLPREDNISOLONE SODIUM SUCCINATE 2024-11-13
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...